ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Scanfil Oyj

Scanfil Oyj (0Q59)

4.05
0.00
(0.00%)
Closed January 05 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.05
Bid
3.95
Ask
4.15
Volume
500
0.00 Day's Range 0.00
4.05 52 Week Range 4.05
Market Cap
Previous Close
4.05
Open
-
Last Trade
500
@
8.42
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
385
Shares Outstanding
65,270,000
Dividend Yield
-
PE Ratio
5.48
Earnings Per Share (EPS)
0.74
Revenue
902.4M
Net Profit
48.22M

About Scanfil Oyj

Sector
Electronic Components, Nec
Industry
Electronic Components Diverse
Website
Headquarters
Sievi, Fin
Founded
2000
Scanfil Oyj is listed in the Electronic Components sector of the London Stock Exchange with ticker 0Q59. The last closing price for Scanfil Oyj was 4.05 €. Over the last year, Scanfil Oyj shares have traded in a share price range of 4.05 € to 4.05 €.

Scanfil Oyj currently has 65,270,000 shares outstanding. The market capitalization of Scanfil Oyj is 264.34 € million. Scanfil Oyj has a price to earnings ratio (PE ratio) of 5.48.

0Q59 Latest News

Scanfil plc: Managers' transactions – Wiklund

Scanfil plc: Managers' transactions – Wiklund Scanfil plc: Managers' transactions     27 April 2022 at 3.00 p.m. EET Scanfil plc: Managers' transactions – Wiklund Person subject to the...

Scanfil Group’s interim report for January–March 2022: Strong demand continued under demanding circumstances

Scanfil Group’s interim report for January–March 2022: Strong demand continued under demanding circumstances Scanfil plc     Interim report     22 April 2022 at 8.00 a.m.Scanfil Group’s...

Decisions of the Annual General Meeting of Scanfil plc on 21 April 2022

Decisions of the Annual General Meeting of Scanfil plc on 21 April 2022 Scanfil plc     Stock exchange release     21 April 2022 at 5.00 p.m. EET Decisions of the Annual General Meeting of...

Scanfil will publish its interim report for January-March 2022 on April 22

Scanfil will publish its interim report for January-March 2022 on April 22 Scanfil plc    Press release    14 April 2022 at 3:00 p.m. EET Scanfil will publish its interim report for...

Scanfil revises its turnover upwards for 2022 and reiterates its outlook for operating profit

Scanfil revises its turnover upwards for 2022 and reiterates its outlook for operating profit Scanfil plc     Inside Information     14 April 2022 at 11.00 a.m. EET Scanfil revises its...

Scanfil plc’s annual report for 2021 has been published

Scanfil plc’s annual report for 2021 has been published Scanfil plc     Stock exchange release     25 March 2022 at 8.00 a.m. EET Scanfil plc’s annual report for 2021 has been published...

Notice to the Scanfil plc’s Annual General Meeting

Notice to the Scanfil plc’s Annual General Meeting Scanfil plc     Stock exchange release     24 March 2022 at 2.30 p.m. EETNotice to the Scanfil plc’s Annual General Meeting The shareholders...

Decision of Scanfil plc’s Board of Directors on stock option plan

Decision of Scanfil plc’s Board of Directors on stock option plan Scanfil plc     Stock Exchange Release    28 February 2022 at 6.00 p.m. Decision of Scanfil plc’s Board of Directors on stock...

Scanfil plc: Managers' transactions – Wiklund

Scanfil plc: Managers' transactions – Wiklund Scanfil plc: Managers' transactions 28 February 2022 5.30 p.m. EET Scanfil plc: Managers' transactions – Wiklund Person subject to the...

Scanfil plc: Managers' transactions – Valo

Scanfil plc: Managers' transactions – Valo Scanfil plc: Managers' transactions     28 February 2022 at 2.00 p.m. EET Scanfil plc: Managers' transactions – Valo Person subject to the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1004.054.054.051634.05DE
4004.054.054.051834.05DE
12004.054.054.053854.05DE
26004.054.054.052024.05DE
52004.054.054.052104.05DE
156004.054.054.052304.05DE
260004.054.054.051494.05DE

0Q59 - Frequently Asked Questions (FAQ)

What is the current Scanfil Oyj share price?
The current share price of Scanfil Oyj is 4.05 €
How many Scanfil Oyj shares are in issue?
Scanfil Oyj has 65,270,000 shares in issue
What is the market cap of Scanfil Oyj?
The market capitalisation of Scanfil Oyj is EUR 264.34M
What is the 1 year trading range for Scanfil Oyj share price?
Scanfil Oyj has traded in the range of 4.05 € to 4.05 € during the past year
What is the PE ratio of Scanfil Oyj?
The price to earnings ratio of Scanfil Oyj is 5.48
What is the cash to sales ratio of Scanfil Oyj?
The cash to sales ratio of Scanfil Oyj is 0.29
What is the reporting currency for Scanfil Oyj?
Scanfil Oyj reports financial results in EUR
What is the latest annual turnover for Scanfil Oyj?
The latest annual turnover of Scanfil Oyj is EUR 902.4M
What is the latest annual profit for Scanfil Oyj?
The latest annual profit of Scanfil Oyj is EUR 48.22M
What is the registered address of Scanfil Oyj?
The registered address for Scanfil Oyj is YRITYSTIE 6, SIEVI, FIN-85410
What is the Scanfil Oyj website address?
The website address for Scanfil Oyj is www.scanfil.com
Which industry sector does Scanfil Oyj operate in?
Scanfil Oyj operates in the ELECTRONIC COMPONENTS DIVERSE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
nowwhat2 nowwhat2 3 minutes ago
editing
https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg
XRPUSD
boi568 boi568 11 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 23 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 25 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 26 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 27 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 28 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 29 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 31 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 32 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 32 minutes ago
Not good, thanks for sharing.
sand sand 39 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 40 minutes ago
Moving hard soon 
EFSH
mining101 mining101 41 minutes ago
Superb
MEGL
benz280c benz280c 48 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 55 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 56 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 59 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hour ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hour ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con